Clinical Trial Update: Lung-MAP S1400K: c-MET Positive [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for c-MET positive recurrent/stage IV squamous cell lung carcinoma (Lung-MAP S1400K) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Lung Carcinoma

Drugs mentioned

• c-MET positive therapy

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 | Phase 2 | Status: COMPLETED | Results posted: 2021-06-29